The UA Doppler Index, Plasma HCY, and Cys C in Pregnancies Complicated by Congenital Heart Disease of the Fetus
Open Access
- 10 October 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (19) , 5962
Abstract
Background: Congenital heart disease/defect (CHD) is one of the most common congenital disabilities. Early diagnosis of CHD can improve the prognosis of newborns with CHD. The aim of this study was to evaluate the relationship between the factors and the onset of fetal congenital heart disease by measuring fetal umbilical artery (UA) Doppler index, maternal HCY, and Cys C levels during pregnancy. Methods: This retrospective study analyzed 202 fetuses with CHD, including 77 cases (39.1%) of simple CHD and 120 cases (60.9%) of complex CHD. Singleton pregnant women who were examined at the same time and whose malformation screening did not suggest any structural abnormalities in the fetus were assigned to the control group (n = 400). The UA Doppler index, plasma HCY, and Cys C levels were compared among the pregnant women across the three groups, and logistic regression analysis was performed on statistically significant markers. The ROC of UA S/D, PI, RI, HCY, and Cys C were plotted, and the area under the ROC (AUC) was calculated. Results: The UA S/D, PI, and RI in the complex CHD group were significantly higher than those in the control group (p < 0.05). The levels of HCY and Cys C in the CHD group were significantly higher than those in the control group (p < 0.05). HCY and S/D revealed a positive correlation (r = 0.157), and the difference was statistically significant (p < 0.001). Cys C and S/D were positively correlated (r = 0.131), and the difference was statistically significant (p < 0.05). The levels of UA Doppler indices, maternal plasma HCY, and Cys C were elevated in fetuses with CHD. The AUC of the combined test of the UA index, HCY, and Cys C was higher than that of each individual test. Conclusions: Elevated levels of the UA doppler indices, HCY, and Cys C during pregnancy are positively associated with the development of congenital heart disease in offspring. The combination of HCY and Cys C was the most efficient test for the diagnosis of CHD. We are the first to report that plasma Cys C levels of women pregnant with fetuses with CHD were higher than those of women pregnant with normal fetuses.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (18411963500)
This publication has 26 references indexed in Scilit:
- Maternal serum placental growth factor at 11–13 weeks' gestation and fetal cardiac defectsUltrasound in Obstetrics & Gynecology, 2013
- ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heartUltrasound in Obstetrics & Gynecology, 2013
- Severe left heart obstruction with retrograde arch flow influences fetal cerebral and placental blood flowUltrasound in Obstetrics & Gynecology, 2013
- Congenital Heart Disease in the General PopulationCirculation, 2007
- Maternal hyperhomocysteinaemia is a risk factor for congenital heart diseaseBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Maternal Homocysteine and Congenital Heart DefectsJACC, 2006
- Congenital heart defects, maternal homocysteine, smoking, and the 677 C>T polymorphism in the methylenetetrahydroflate reductase gene: Evaluating gene-environment interactionsAmerican Journal of Obstetrics and Gynecology, 2006
- Genotype and Plasma Concentration of Cystatin C in Patients With Coronary Heart Disease and Risk for Secondary Cardiovascular EventsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- HOMOCYSTEINE, FOLATE, AND CONGENITAL HEART DEFECTSFetal and Pediatric Pathology, 2005
- Blood redistribution in the fetal brain during chronic hypoxiaUltrasound in Obstetrics & Gynecology, 2002